Multiple award BPA; modernizing FDA data and analytics deloitte see also 75F40124A00008; 75F40124A00009; 75F40124A00011; 75F40124A00012

Ended Awarded Last action

Contract number
75F40124A00010
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 75F40123Q00038 Solicitation number
Last date to order 100% complete
IDV ceiling
$500,000,000.00
Maximum order
$500,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 23 offers Multiple Award, Fair Opportunity
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration awarded a multiple-award Blanket Purchase Agreement (BPA) to Deloitte Consulting LLP for modernizing FDA data and analytics capabilities. This contract, with a ceiling value of $500 million and an ultimate completion date of May 5, 2025, was awarded on August 26, 2024, without a small business set-aside. As a child contract under the master "Modernizing FDA Data and Analytics" BPA, this vehicle enables the FDA to procure flexible, task-order-based professional services supporting the agency's data infrastructure and analytical capabilities. Deloitte, headquartered in Arlington, Virginia, is a large for-profit management and technology consulting firm with extensive federal contracting experience and demonstrated expertise in data analytics, IT modernization, and business intelligence solutions for civilian agencies.

Under this BPA, Deloitte will deliver comprehensive data analytics, business intelligence, and system modernization services designed to enhance the FDA's regulatory mission and decision-making processes. The contract supports the agency's cost efficiency initiative objectives and aligns with Deloitte's established service portfolio in data-driven solutions for federal regulators. Given the FDA's regulatory responsibilities across pharmaceuticals, medical devices, and food safety, the modernized data and analytics infrastructure will likely enable improved compliance monitoring, risk assessment, and evidence-based policy decisions. The multiple-award structure of this BPA indicates that other contractors may hold complementary vehicles under the same master agreement, promoting competition while leveraging pre-negotiated terms and pricing that facilitate rapid task order execution across the agency's analytical requirements.

Transactions

Action Obligated Date
Terminate for Convenience P00002 $0
Terminate for Convenience P00001 · EOI: HHS cost efficiency initiative: EOI termination for convenience agreement multiple award BPA; modernizing FDA data and analytics deloitte see also… $0
Original award $0

Quick answers

Who was awarded contract 75F40124A00010?

75F40124A00010 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on August 26, 2024.

How much is contract 75F40124A00010 worth?

75F40124A00010's own ceiling is $500,000,000. A single order can be worth up to $500,000,000.

Who can order from contract 75F40124A00010?

75F40124A00010 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 75F40124A00010 under another contract?

Yes. 75F40124A00010 is a blanket purchase agreement under 47QRAA18D001P, a federal supply schedule, on Modernizing FDA Data and Analytics.

Was contract 75F40124A00010 competed?

The extent of competition for 75F40124A00010 was full and open competition. The government received 23 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV